AACR Annual Meeting 2017: First Analyses of AACR Project GENIE Data Presented in Major Symposium
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...
How AACR Project GENIE Is Helping Unravel the Mysteries of Cancer
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
AACR Annual Meeting 2021: AACR Project GENIE Powers Research on Cancer Disparities and Clinical Outcomes
The term “cancer” encompasses a broad range of diseases that can afflict almost any organ of the body. Not only do molecular features...
AACR Project GENIE: Advancing Cancer Research Through Data Sharing
AACR Project Genomics Evidence Neoplasia Information Exchange, or GENIE for short, has released one of the largest fully public...
AACR Virtual Annual Meeting I: Insights Gained from AACR Project GENIE
The unrestrained cellular proliferation that characterizes cancer largely arises due to genetic mutations, which can impede the regulatory mechanisms that control when and how often a cell divides. Genetic mutations may also...
Recent Studies Tap Into AACR Project GENIE Registry
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
Two New Studies Highlight the Broad Utility of AACR Project GENIE Data
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation...
Annual Meeting 2022: AACR Project GENIE Delivers More Treasure
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
AACR Project GENIE: More Data, More Participants, and More Progress
AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently hit another milestone: the public release of a fourth dataset,...
AACR Project GENIE: The Sharing Economy Comes to the Clinic
Guest Post by Charles L. Sawyers, MD AACR Project GENIE Steering Committee Chairperson
AACR Project GENIE® Contributes Data to Global Hackathon
The term “hackathon” may conjure up images of beanie-wearing coders working in dark basements, trying to build a new...
Genentech Supports AACR Project GENIE
The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently received funding from Genentech...
Publicly Available Databases: Closing the Gap in Cancer Health Disparities Research
Cancer health disparities are driven by the compounding of multiple factors, including gaps in research resulting from insufficient representation...
COVID-19 and Cancer Consortium Forms to Collect and Share Information
Guest post by Jeremy Warner, MD, MS, and Deborah Doroshow, MD, PhD The world is facing a pandemic unlike...
With Push to Advance Cancer Research, Technology Plays Vital Role in Vice President Biden’s Cancer Initiative
Whether cures for cancer are realized through personalized medicine, cancer vaccines, immunotherapy, or a combination of these or other...
World Cancer Day: AACR’s Efforts to Close the Care Gap
The AACR supports the mission of World Cancer Day 2024 to Close the Care Gap, which it has worked...
Experts Forecast Cancer Research and Treatment Advances in 2016
We asked experts in cancer precision medicine, immunotherapy, and prevention what breakthroughs we might expect to see in 2016...
In the News: AACR President Nancy E. Davidson, MD, on Capturing the Moonshot’s Momentum
AACR President Nancy E. Davidson, MD, discusses her goals for her Presidential year at the AACR in an editorial...
AACR In the News
The American Association for Cancer Research (AACR) has appeared in numerous publications lately, showcasing the breadth of our mission...
AACR Blog Turns 3: Check Out Our Top 10 Posts
Three years ago, the American Association for Cancer Research (AACR) launched this blog with a welcome post from Chief...
Putting an End to Cancer Health Disparities
Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the...
FDA-AACR Workshop Examines the Practice and Promise of Real-world Evidence in Oncology
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
Molecular Targets 2021: The Latest Efforts to Overcome Resistance to KRAS Inhibitors
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
Editors’ Picks: November Highlights from the AACR Journals
With Thanksgiving behind us here in the United States, the holiday season is in full swing. So, grab some...
Seeking Clues to Early-onset Colorectal Cancer
The 2020 death of actor Chadwick Boseman shocked the public, sparking grief in those who revered his portrayal of...
AACR Annual Meeting 2023: Opening Ceremony Heralds Extraordinary Science
As 21,000 cancer researchers, clinicians, policymakers, and patient advocates thronged the Orange County Convention Center, Margaret Foti, PhD, MD...
10 Most Popular Cancer Research Catalyst Blog Posts of 2015
It’s that time of year when we reflect on the progress we made over the past 12 months –...
Leading Cancer Experts Comment on the Cancer Initiative in the State of the Union Address
Editor’s Note: Several prominent American Association for Cancer Research (AACR) leaders have shared their reactions to President Obama’s Jan....
Vice President Joe Biden Speaks at the AACR Annual Meeting 2016
Vice President Joe Biden spoke at the AACR Annual Meeting 2016 about the importance of breaking silos and promoting...
Can Big Data Launch Cancer Research?
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today In his 2016 State of the Union address, President...